fbpx
News
September 9, 2014

In The News Today – September 9, 2014

The FTC has sued AbbVie along with other drug companies after they allegedly “unlawfully sought to delay generic competition” on a “testosterone-replacement drug” called AndroGel by filing “baseless patent-infringement litigation.” (Wall Street Journal)

Cookie Notice

By clicking “I Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

Cookie Notice

By clicking “I Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. Review Settings